This is a community-generated profile. If you would like to claim it, please .
Celldex Therapeutics
Develops antibody-based therapies for inflammatory diseases and cancer51-200 EmployeesActively Hiring
Celldex Therapeutics Funding
$460.5M
11 round
Celldex Therapeutics is active in the following markets / industries: biotechnology. The company has secured funding across 1 rounds, totaling in an amount of $460.5M. Their most recent funding was raised on February 29, 2024.
Funding Rounds
S
$460500000